PolyPid Ltd. will hold a virtual Investor Day on October 28, 2026, to present its long-term growth plan 'PolyPid 2030' and update on its lead product D-PLEX₁₀₀, which is under FDA Priority Review with a decision expected by November 28, 2026. The event will also introduce PD01B, a new candidate for diabetic foot infections, featuring expert Dr. Warren S. Joseph discussing treatment challenges and innovations. This event highlights PolyPid's focus on advancing controlled-release antibiotic therapies to improve surgical and infection care outcomes.
PolyPid's upcoming Virtual Investor Day on October 28, 2026, is noted here with Pluang's Health-sector market snapshot as of Oct 15, 2026 19:31 WIB: out of 150 priced US Health stocks, 95 rose and 46 fell. Among notable movers, Recursion Pharmaceuticals Inc (RXRX) traded at USD 3.41 with a 1-day change of -8.82% and a Pluang order activity of 73% Sell / 27% Buy, while Nuwellis Inc (NUWE) rose 5.72% to USD 0.56 despite 75% Sell activity. Twist Bioscience Corp (TWST) was priced at USD 141.01, down 4.83%, with nearly balanced order activity. The most notable figure is RXRX's 73% sell order activity on Pluang.
The Saudi Arabia Non-Invasive Prenatal Testing (NIPT) market is projected to grow from $52.5 million in 2025 to $162.16 million by 2034, at a CAGR of 13.35%. Growth is fueled by rising maternal age, advances in molecular diagnostics, and increased he...
TiDB, powered by PingCAP, announced new cloud platform capabilities to support enterprise and AI applications on a unified data foundation. Key updates include the upcoming general availability of TiDB Cloud Premium, public previews of Bring Your Own...
Alcoa will release its Q3 2026 earnings on October 15, with analysts divided on earnings per share and revenue forecasts due to factors like rising aluminum sales, inventory changes, and higher input costs. The company expects a 54.9% jump in aluminu...
Nokia has transferred 2,142,361 of its own shares to employees participating in its stock-based incentive programs, as per a board decision announced in October 2025. This transfer was made without compensation and is part of fulfilling commitments u...
Pallavi Mahajan, a senior manager at Nokia Corporation, received 35,192 shares through a share-based incentive on October 15, 2026. This transaction was reported under EU Market Abuse Regulation, reflecting Nokia's ongoing use of equity incentives to...
